English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
otosclerosis/edema
The link is saved to the clipboard
10 results
.beta.- and .gamma.-diketones and .gamma.-hydroxyketones as WNT/ .beta.-catenin signaling pathway activators
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to activators of one or more proteins in the Wnt pathway, including activators of one or more Wnt proteins, and compositions comprising the same. More particularly, it concerns the use of a .beta.-diketone, .gamma.-diketone
.beta.- and .gamma.-diketones and .gamma.-hydroxyketones as WNT/ .beta.-catenin signaling pathway activators
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to activators of one or more proteins in the Wnt pathway, including activators of one or more Wnt proteins, and compositions comprising the same. More particularly, it concerns the use of a .beta.-diketone, .gamma.-diketone
.beta.- and .gamma.-diketones and .gamma.-hydroxyketones as WNT/.beta.-catenin signaling pathway activators
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to activators of one or more proteins in the Wnt pathway, including activators of one or more Wnt proteins, and compositions comprising the same. More particularly, it concerns the use of a .beta.-diketone, .gamma.-diketone
.beta.- and .gamma.-diketones and .gamma.-hydroxyketones as Wnt/.beta.-catenin signaling pathway activators
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to activators of one or more proteins in the Wnt pathway, including activators of one or more Wnt proteins, and compositions comprising the same. More particularly, it concerns the use of a .beta.-diketone, .gamma.-diketone
.beta.- and .gamma.-diketones and .gamma.-hydroxyketones as Wnt/.beta.-catenin signaling pathway activators
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
Field of the Invention
This invention relates to activators of one or more proteins in the Wnt pathway, including activators of one or more Wnt proteins, and compositions comprising the same. More particularly, it concerns the use of a .beta.-diketone, .gamma.-diketone or
.beta.- and .gamma.-diketones and .gamma.-hydroxyketones as Wnt/ .beta.-catenin signaling pathway activators
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
Field of the Invention
This invention relates to activators of one or more proteins in the Wnt pathway, including activators of one or more Wnt proteins, and compositions comprising the same. More particularly, it concerns the use of a .beta.-diketone, .gamma.-diketone or
.beta.- and .gamma.-diketones and .gamma.-hydroxyketones as WNT/.beta.-catenin signaling pathway activators
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
Field of the Invention
This invention relates to activators of one or more proteins in the Wnt pathway, including activators of one or more Wnt proteins, and compositions comprising the same. More particularly, it concerns the use of a .beta.-diketone, .gamma.-diketone or
.gamma.-diketones as Wnt/.beta.-catenin signaling pathway activators
Only registered users can translate articles
Log In/Sign up
BACKGROUND
Technical Field
This disclosure relates to activators of one or more proteins in the Wnt pathway, including activators of one or more Wnt proteins, and compositions comprising the same. More particularly, it concerns the use of a .gamma.-diketones or salts or analogs thereof, in the
.gamma.-diketones as Wnt/.beta.-catenin signaling pathway activators
Only registered users can translate articles
Log In/Sign up
BACKGROUND
Technical Field
This disclosure relates to activators of one or more proteins in the Wnt pathway, including activators of one or more Wnt proteins, and compositions comprising the same. More particularly, it concerns the use of a .gamma.-diketones or salts or analogs thereof, in the
.gamma.-diketones as WNT/.beta.-catenin signaling pathway activators
Only registered users can translate articles
Log In/Sign up
BACKGROUND
Technical Field
This disclosure relates to activators of one or more proteins in the Wnt pathway, including activators of one or more Wnt proteins, and compositions comprising the same. More particularly, it concerns the use of a .gamma.-diketones or salts or analogs thereof, in the
The most complete medicinal herbs database backed by science
- Works in 55 languages
- Herbal cures backed by science
- Herbs recognition by image
- Interactive GPS map - tag herbs on location (coming soon)
- Read scientific publications related to your search
- Search medicinal herbs by their effects
- Organize your interests and stay up do date with the news research, clinical trials and patents
Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research
